Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
Minerva Neurosciences (NERV) - Net assets
Net assets on the balance sheet as of December 2023 : -$28.46 M
According to Minerva Neurosciences
's latest financial reports the company has -$28.46 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Minerva Neurosciences - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-28.46 M | 42.12% |
| 2022-12-31 | $-20.03 M | -351.07% |
| 2021-12-31 | $7.97 M | -84.86% |
| 2020-12-31 | $52.66 M | 89.57% |
| 2019-12-31 | $27.77 M | -69.22% |
| 2018-12-31 | $90.26 M | -31.41% |
| 2017-12-31 | $0.13 B | 24.17% |
| 2016-12-31 | $0.10 B | 91.58% |
| 2015-12-31 | $55.31 M | 7.42% |
| 2014-12-31 | $51.49 M | 155.21% |
| 2013-12-31 | $20.17 M | 106002.33% |
| 2012-12-31 | $0.01 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Incyte INCY | $5.18 B | -18,337.16% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.62 B | -2,285.97% | 🇺🇸 USA |
 Clovis Oncology CLVS | -$0.42 B | 1,368.46% | 🇺🇸 USA |